Target Controlled Infusion of Propofol

0

Pipeline Programs↗

0

Active Trials↗

0

Companies Involved↗

Target Controlled Infusion of Propofol is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

0/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

N/A

Attrition Rate

0/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

2

clinical trials

Unknown status2 · 100%

Clinical Trials

Trial Activity

Dexmedetomidine Combined With the Closed Loop of Target Controlled Infusion of Propofol for Anesthesia With Intraoperative Wake up

Unknown status·SSecond Affiliated Hospital of Xi'an Jiaotong University·Phase 4·NCT02143362·60 enrolled

THe Comparison of Target Controlled Infusion of Propofol or Etomidate at General Anesthesia in Geriatric Patients

Unknown status·SSecond Affiliated Hospital of Xi'an Jiaotong University·Phase 4·NCT02111265·90 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)